M

ME Therapeutics Holdings
METX

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
CA$235.71M
EV
CA$233.81M
Shares Outstanding
33.47M
Beta
-

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E undefinedE
-
P/Revenue undefinedE
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About ME Therapeutics Holdings Inc.

gainify

M

ME Therapeutics Holdings Inc.

METX

ME Therapeutics Holdings Inc., a preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno‐oncology. Its lead candidate is a novel antibody drug that targets a key protein involved in the generation of suppress...

Sector

Industry

CEO

Dhanji, Salim

Employees

IPO Date

Headquarters

177 Robson Street, Vancouver, British Columbia, V6B 0N3, Canada

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved